BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 19576785)

  • 21. Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity.
    Fourie J; Guziec F; Guziec L; Monterrosa C; Fiterman DJ; Begleiter A
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):191-203. PubMed ID: 14614574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel nitrogen mustard-armed combi-molecules for the selective targeting of epidermal growth factor receptor overexperessing solid tumors: discovery of an unusual structure-activity relationship.
    Rachid Z; Brahimi F; Qiu Q; Williams C; Hartley JM; Hartley JA; Jean-Claude BJ
    J Med Chem; 2007 May; 50(11):2605-8. PubMed ID: 17472358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitomycin dimers: polyfunctional cross-linkers of DNA.
    Paz MM; Kumar GS; Glover M; Waring MJ; Tomasz M
    J Med Chem; 2004 Jun; 47(12):3308-19. PubMed ID: 15163210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor efficacy and molecular mechanism of TLK58747, a novel DNA-alkylating prodrug.
    Xu H; Wang Z; Donaldson JC; Yao H; Zhou S; Kelson AB; Ma W; Weber KT; Laborde E; Cheng M; Sambucetti L; Keck JG
    Anticancer Res; 2009 Oct; 29(10):3845-55. PubMed ID: 19846918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel.
    Yamori T; Matsunaga A; Sato S; Yamazaki K; Komi A; Ishizu K; Mita I; Edatsugi H; Matsuba Y; Takezawa K; Nakanishi O; Kohno H; Nakajima Y; Komatsu H; Andoh T; Tsuruo T
    Cancer Res; 1999 Aug; 59(16):4042-9. PubMed ID: 10463605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and antiproliferative evaluation of 6-arylindeno[1,2-c]quinoline derivatives.
    Tseng CH; Chen YL; Chung KY; Cheng CM; Wang CH; Tzeng CC
    Bioorg Med Chem; 2009 Nov; 17(21):7465-76. PubMed ID: 19796956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and antitumor activity of 5-(9-acridinylamino)anisidine derivatives.
    Bacherikov VA; Chang JY; Lin YW; Chen CH; Pan WY; Dong H; Lee RZ; Chou TC; Su TL
    Bioorg Med Chem; 2005 Dec; 13(23):6513-20. PubMed ID: 16140018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Syntheses and antiproliferative activities of 7-azarebeccamycin analogues bearing one 7-azaindole moiety.
    Marminon C; Pierré A; Pfeiffer B; Pérez V; Léonce S; Joubert A; Bailly C; Renard P; Hickman J; Prudhomme M
    J Med Chem; 2003 Feb; 46(4):609-22. PubMed ID: 12570382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BINOL-amino acid conjugates as triggerable carriers of DNA-targeted potent photocytotoxic agents.
    Doria F; Richter SN; Nadai M; Colloredo-Mels S; Mella M; Palumbo M; Freccero M
    J Med Chem; 2007 Dec; 50(26):6570-9. PubMed ID: 18047263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of new bifunctional compounds which selectively alkylate guanines in DNA.
    Henderson ND; Lacy SM; O'Hare CC; Hartley JA; McClean S; Wakelin LP; Kelland LR; Robins DJ
    Anticancer Drug Des; 1998 Oct; 13(7):749-68. PubMed ID: 9807160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapy.
    Hay MP; Anderson RF; Ferry DM; Wilson WR; Denny WA
    J Med Chem; 2003 Dec; 46(25):5533-45. PubMed ID: 14640560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, and in vitro evaluation of dipeptide-based antibody minor groove binder conjugates.
    Jeffrey SC; Torgov MY; Andreyka JB; Boddington L; Cerveny CG; Denny WA; Gordon KA; Gustin D; Haugen J; Kline T; Nguyen MT; Senter PD
    J Med Chem; 2005 Mar; 48(5):1344-58. PubMed ID: 15743178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relationships for 4-nitrobenzyl carbamates of 5-aminobenz[e]indoline minor groove alkylating agents as prodrugs for GDEPT in conjunction with E. coli nitroreductase.
    Hay MP; Atwell GJ; Wilson WR; Pullen SM; Denny WA
    J Med Chem; 2003 Jun; 46(12):2456-66. PubMed ID: 12773049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and structure-activity relationships of ring-opened 17-hydroxywortmannins: potent phosphoinositide 3-kinase inhibitors with improved properties and anticancer efficacy.
    Zask A; Kaplan J; Toral-Barza L; Hollander I; Young M; Tischler M; Gaydos C; Cinque M; Lucas J; Yu K
    J Med Chem; 2008 Mar; 51(5):1319-23. PubMed ID: 18269228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of autophagy enhances DNA damage-induced apoptosis by disrupting CHK1-dependent S phase arrest.
    Liou JS; Wu YC; Yen WY; Tang YS; Kakadiya RB; Su TL; Yih LH
    Toxicol Appl Pharmacol; 2014 Aug; 278(3):249-58. PubMed ID: 24823293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenine-containing DNA-DNA cross-links of antitumor nitrogen mustards.
    Balcome S; Park S; Quirk Dorr DR; Hafner L; Phillips L; Tretyakova N
    Chem Res Toxicol; 2004 Jul; 17(7):950-62. PubMed ID: 15257621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of novel chloroethylaminoanthraquinones with potent cytotoxic activity against cisplatin-resistant tumor cells.
    Pors K; Paniwnyk Z; Ruparelia KC; Teesdale-Spittle PH; Hartley JA; Kelland LR; Patterson LH
    J Med Chem; 2004 Mar; 47(7):1856-9. PubMed ID: 15027879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergy of irofulven in combination with other DNA damaging agents: synergistic interaction with altretamine, alkylating, and platinum-derived agents in the MV522 lung tumor model.
    Kelner MJ; McMorris TC; Rojas RJ; Estes LA; Suthipinijtham P
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):19-26. PubMed ID: 18305940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chloroacetaldehyde: mode of antitumor action of the ifosfamide metabolite.
    Brüggemann SK; Radike K; Braasch K; Hinrichs J; Kisro J; Hagenah W; Peters SO; Wagner T
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):349-56. PubMed ID: 16133533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-linking and sequence-specific alkylation of DNA by aziridinylquinones. 3. Effects of alkyl substituents.
    Hargreaves RH; O'Hare CC; Hartley JA; Ross D; Butler J
    J Med Chem; 1999 Jun; 42(12):2245-50. PubMed ID: 10377230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.